Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)

This grant funds research on novel therapies for adult glioblastoma, supporting agents that can cross the blood-brain barrier and moving them from late pre-clinical work through early (Phase 0/1) clinical studies. It supports collaborative teams that develop new or repurposed drugs, conduct IND studies, and run pilot human trials.

Amount: up to $700,000
Type: Grant

Key facts

Key facts for Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
Amount	up to $700,000
Issuer	National Institutes of Health
Who can apply	Small businesses, companies, universities and 7 more
Sectors	HealthTech
Deadline	Closes 11 Jan 2027

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked just now

53 days agoagentImported from the official source

Opportunities with the same funding type or region
European Degree Exploratory Action		Closes 18 Feb 2027
Cooperative Agreement for affiliated Partner with Alaska Cooperative Ecosystem Studies Unit	up to $234,460	Closes 07 Dec 2026
Cooperative Agreement for affiliated Partner with Colorado Plateau Cooperative Ecosystem Studies Unit	up to $150,000	Closes 07 Dec 2026